BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23521603)

  • 1. Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer.
    Vergati M; Della-Morte D; Ferroni P; Cereda V; Tosetto L; La Farina F; Guadagni F; Roselli M
    Rejuvenation Res; 2013 Jun; 16(3):224-31. PubMed ID: 23521603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chemotherapy on activated protein C-dependent thrombin generation--association with VTE occurrence.
    Roselli M; Ferroni P; Riondino S; Mariotti S; Laudisi A; Vergati M; Cavaliere F; Palmirotta R; Guadagni F
    Int J Cancer; 2013 Sep; 133(5):1253-8. PubMed ID: 23404208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
    Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
    Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.
    Kuderer NM; Culakova E; Lyman GH; Francis C; Falanga A; Khorana AA
    Oncologist; 2016 Jul; 21(7):861-7. PubMed ID: 27125754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy - a cohort study.
    Zahir MN; Shaikh Q; Shabbir-Moosajee M; Jabbar AA
    BMC Cancer; 2017 Jan; 17(1):57. PubMed ID: 28093087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
    Khorana AA; Dalal M; Lin J; Connolly GC
    Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in patients with cholangiocarcinoma: focus on risk factors and impact on survival.
    Jeon HK; Kim DU; Baek DH; Ha DW; Lee BE; Ryu DY; Cheong JH; Kim GH; Song GA; Jang AL
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):444-9. PubMed ID: 22410715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE.
    Yhim HY; Jang MJ; Kwak JY; Yim CY; Choi WI; Lee YC; Lee JO; Lee KW; Bang SM; Kim SH; Kim YK; Chang HJ; Oh D;
    Thromb Res; 2013 Apr; 131(4):e133-40. PubMed ID: 23399441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients.
    Piran S; Ngo V; McDiarmid S; Le Gal G; Petrcich W; Carrier M
    Thromb Res; 2014 Jan; 133(1):30-3. PubMed ID: 24188799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients.
    Ferroni P; Martini F; Portarena I; Massimiani G; Riondino S; La Farina F; Mariotti S; Guadagni F; Roselli M
    Clin Lung Cancer; 2012 Nov; 13(6):482-7. PubMed ID: 22591606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.
    Agnelli G; George DJ; Kakkar AK; Fisher W; Lassen MR; Mismetti P; Mouret P; Chaudhari U; Lawson F; Turpie AG;
    N Engl J Med; 2012 Feb; 366(7):601-9. PubMed ID: 22335737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients.
    Ferroni P; Palmirotta R; Riondino S; De Marchis ML; Nardecchia A; Formica V; Guadagni F; Roselli M
    Thromb Haemost; 2016 Jan; 115(1):143-51. PubMed ID: 26336029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy.
    Ferroni P; Guadagni F; Laudisi A; Vergati M; Riondino S; Russo A; Davì G; Roselli M
    Oncologist; 2014 May; 19(5):562-7. PubMed ID: 24710308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
    Khorana AA; Francis CW; Culakova E; Lyman GH
    Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study.
    Ferroni P; Martini F; Portarena I; Grenga I; Riondino S; La Farina F; Laudisi A; Guadagni F; Roselli M
    Support Care Cancer; 2012 Nov; 20(11):2713-20. PubMed ID: 22322591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients.
    Gonzalez-Billalabeitia E; Castellano D; Sobrevilla N; Guma J; Hervas D; Luengo MI; Aparicio J; Sanchez-Muñoz A; Mellado B; Saenz A; Valverde C; Fernandez A; Margeli M; Duran I; Fernandez S; Sastre J; Ros S; Maroto P; Manneh R; Cerezuela P; Carmona-Bayonas A; Ayala de la Peña F; Luis Aguilar J; Rivera S; García Del Muro X; Germà-Lluch JR;
    J Natl Cancer Inst; 2017 Jan; 109(4):. PubMed ID: 28122896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-O blood type is associated with an increased risk of venous thromboembolism after radical cystectomy.
    Wang JK; Boorjian SA; Frank I; Tarrell RF; Thapa P; Jacob EK; Tauscher CD; Tollefson MK
    Urology; 2014 Jan; 83(1):140-5. PubMed ID: 24139524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
    Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
    World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of venous thromboembolism in the setting of hematopoietic cell transplantation.
    O'Hara VJ; Miller T; Mehta R; Swartzendruber E; Kiel PJ
    Am J Ther; 2014; 21(1):15-9. PubMed ID: 24061558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.